HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aleksander Maciag Selected Research

Antazoline (Antazoline Phosphate)

1/2019Intravenous antazoline, a first-generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio-venous conduction and high clinical effectiveness (AntaEP Study).
12/2018Clinical effectiveness and safety of antazoline-based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short-duration atrial fibrillation in the emergency department.
10/2017Efficacy and safety of antazoline in the rapid cardioversion of paroxysmal atrial fibrillation (the AnPAF Study).
9/2012Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation--a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aleksander Maciag Research Topics

Disease

9Atrial Fibrillation
01/2019 - 10/2002
6Heart Failure
10/2017 - 04/2004
5Cardiac Arrhythmias (Arrythmia)
01/2020 - 10/2006
5Cardiac Sudden Death (Sudden Cardiac Arrest)
09/2010 - 10/2005
3Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
12/2019 - 10/2005
3Ventricular Tachycardia
09/2010 - 12/2003
2Reciprocating Tachycardia
11/2016 - 12/2014
2Supraventricular Tachycardia
12/2014 - 09/2010
1Infections
01/2020
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2018
1Tachycardia (Tachyarrhythmias)
10/2017
1Cardiomyopathies (Cardiomyopathy)
04/2012
1Shock
09/2010
1Sinus Tachycardia
09/2010
1Ventricular Fibrillation
09/2010
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
10/2006
1Thrombosis (Thrombus)
10/2005
1Hemorrhage
10/2002

Drug/Important Bio-Agent (IBA)

4Antazoline (Antazoline Phosphate)FDA Link
01/2019 - 09/2012
2vernakalantIBA
12/2018 - 09/2012
1Pharmaceutical PreparationsIBA
01/2019
1Amiodarone (Amiodarona)FDA LinkGeneric
12/2018
1ORALIT (ORS)IBA
09/2015
1Anti-Arrhythmia AgentsIBA
09/2012
1Heparin (Liquaemin)FDA LinkGeneric
10/2005

Therapy/Procedure

8Therapeutics
12/2018 - 10/2002
6Electric Countershock (Cardioversion)
01/2019 - 10/2002
5Defibrillators (Defibrillator)
09/2007 - 10/2002
4Catheter Ablation
01/2020 - 12/2003
4Radiofrequency Ablation
11/2016 - 09/2010
3Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
12/2019 - 10/2005
2Cardiac Resynchronization Therapy
10/2014 - 10/2006
1Cardiac Resynchronization Therapy Devices
10/2014
1Secondary Prevention
09/2010
1Resuscitation
09/2007
1Electrodes (Electrode)
10/2006